Clinical Study in Post-operation Treatment of Cervical Cancer
NCT01418859 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 183
Last updated 2012-03-21
Summary
The purpose of the research is to evaluate the effect of additional chemotherapy in postoperation therapy of cervical cancer patients with risk factors (big tumor, deep invasion or tumor thrombi in the vascular system).
Conditions
Sponsors & Collaborators
-
Xi'an Jiaotong University
lead OTHER
Principal Investigators
-
Chen M W, M.D · Affiliated Hospital of Medical College of Xo'an Jiaotong University
Eligibility
- Min Age
- 20 Years
- Max Age
- 70 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-08-31
- Primary Completion
- 2012-12-31
- Completion
- 2015-12-31
Countries
- China
Study Locations
More Related Trials
-
The Clinical Research of Neoadjuvant Chemotherapy Combined Surgery for Locally Advanced Cervical Cancer
NCT02471027 ·Status: UNKNOWN
-
Systemic Consolidation Therapy After Chemoradiation Therapy Following Operation for High Risk Early Stage Cervical Cancer
NCT00592059 ·Status: UNKNOWN
-
Topotecan, Cisplatin and Bevacizumab for Recurrent/Persistent Cervical Cancer
NCT00548418 ·Status: COMPLETED ·Phase: PHASE2
-
Carboplatin and Topotecan in Treating Patients With Relapsed or Metastatic Cervical Cancer
NCT00807079 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Capecitabine in Treating Patients With Persistent or Recurrent Cervical Cancer
NCT00039442 ·Status: COMPLETED ·Phase: PHASE2
-
Study on Paclitaxel Plus Topotecan in Comparison With Topotecan Plus Cisplatin in Recurrent or Persistent Cervical Carcinoma
NCT01405235 ·Status: UNKNOWN ·Phase: PHASE3
-
Efficacy Study of Weekly Topotecan With Cisplatin in Advanced Stage or Recurrent Cervical Cancer
NCT00322920 ·Status: TERMINATED ·Phase: PHASE1
-
A Study on the Efficacy and Safety of Bevacizumab in Untreated Patients With Locally Advanced Cervical Cancer
NCT04138992 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Topotecan in Treating Women With Persistent or Recurrent Cervical Cancer
NCT00087126 ·Status: COMPLETED ·Phase: PHASE2
-
Radiation Therapy and Chemotherapy in Treating Patients With Locally Advanced Cervical Cancer
NCT00054444 ·Status: COMPLETED ·Phase: PHASE1
-
A Multicenter, Prospective, Randomized Trial of Adjuvant Chemotherapy for Early-Stage Cervical Cancer Patients
NCT01755897 ·Status: COMPLETED ·Phase: NA
-
Neoadjuvant Chemotherapy and Radical Surgery in Stage IIB Cervical Cancer
NCT02595554 ·Status: UNKNOWN ·Phase: PHASE3
-
Niraparib Combined With Brivanib or Toripalimab in Patients With Cervical Cancer
NCT04395612 ·Status: UNKNOWN ·Phase: PHASE2
-
Topotecan, Cisplatin, and Radiation Therapy in Treating Patients With Advanced Cervical Cancer
NCT00287911 ·Status: COMPLETED ·Phase: PHASE1
-
Capecitabine in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer
NCT00016926 ·Status: COMPLETED ·Phase: PHASE2
-
Belotecan (CKD-602) in Recurrent or Progressive Carcinoma of Uterine Cervix
NCT00430144 ·Status: COMPLETED ·Phase: PHASE2
-
The Efficacy of Adjuvant Chemotherapy in Locally Advanced Cervical Cancer
NCT04409860 ·Status: RECRUITING ·Phase: NA
-
Chemotherapy Followed By Surgery Vs Radiotherapy Plus Chemotherapy in Patients With Stage IB or II Cervical Cancer
NCT00039338 ·Status: UNKNOWN ·Phase: PHASE3
-
Concurrent Chemoradiotherapy for Cervical Cancer in Elderly Women
NCT01594099 ·Status: UNKNOWN ·Phase: PHASE2
-
First-line Chemotherapy for Recurrent Cervical Cancer
NCT04188847 ·Status: COMPLETED ·Phase: PHASE2
-
Apatinib and Chemotherapy Sequential Treatment With Cervical Cancer
NCT03029013 ·Status: UNKNOWN ·Phase: NA
-
A Trial of TQB2868 Plus Platinum-based Chemotherapy With or Without Bevacizumab in the First-line Treatment of Persistent, Recurrent, or Metastatic Cervical Cancer
NCT05998941 ·Status: WITHDRAWN ·Phase: PHASE2
-
Effectiveness of Chemotherapy in Metastatic or Recurrent Carcinoma Cervix
NCT02492503 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Comparing Study Between Concurrent Chemoradiation and New Combination Treatment in Cervical Cancer Patients
NCT01000415 ·Status: UNKNOWN ·Phase: PHASE3
-
Induction Toripalimab and Chemotherapy in Locally Advanced Cervical Cancer
NCT06093438 ·Status: RECRUITING ·Phase: PHASE1/PHASE2